- BUZZ - SmartStop Self Storage REIT pulls back from all-time highs after nearly $302 million stock offering
- Acala and Karura Move to Sunset Both Chains by February 10, 2027
- SABESP Fiscal Council Backs R$ 2.64 Billion Interest on Equity Payout
- Entegris Board Authorizes $500 Million Share Repurchase Program
- Rio2 Q3 2026 net loss widens to USD 28.45 million
- Thunder Gold Intersects 0.531 g/t Gold Over 388.5 Meters at Tower Mountain
- BrainsWay Q3 2026 operating income more than doubles year over year to $2.6 million; revenue rises 34% to $18.1 million
- Kalaris Therapeutics Q3 net loss narrows 7% to $11.03 million
- Abaxx Names Jeff Currie Non-Executive Chairman
- Exagen Q3 net loss narrows 11% to $6.34 million; Q3 revenue rises 7% to $18.42 million
- Pasinex Resources Resumes Exploration Drilling at Pinargozu Zinc Mine in Turkiye
- Tartisan Nickel Proposes 1,200-Meter Drill Program at Sill Lake Silver Project
- Silver North extends Haldane silver mineralization 100 meters southwest in step-out drilling
- Abeona Therapeutics to Participate in Stifel and Jefferies Healthcare Conferences
- SKF sets Nov. 27 record date for SKF Vertevo share distribution
- Caprock Mining drilling confirms gold mineralization continuity at Destiny project
- Plurilock Urges Shareholders to Approve Acquisition by Quantum eMotion
- Borealis Mining FY26 net loss narrows 68% to USD 4.74 million
- Dyadic partners with BRIG BIO, Strive Nutrition to develop precision-fermented alpha-lactalbumin
- Manhattan Uranium identifies 18 priority drill targets at October project
- What will flip the US Dollar's trajectory as inflation cools toward the Fed's 2% target in 2027?
- Solstice Gold expands geophysical survey at Strathy gold project
- NowVertical Q3 2026 Operating Income Jumps 53% to USD 600,000; Revenue Rises 11% to USD 10.1 Million
- CVS HEALTH CORPORATION <CVS.N>: ARGUS RESEARCH CUTS TARGET PRICE TO $105 FROM $114
- PMGC Holdings Subscribes for Shares in Australian Space Technology Company Orbit2Orbit
- VIAVI SOLUTIONS INC. <VIAV.O>: ARGUS RESEARCH CUTS TARGET PRICE TO $52 FROM $66
- Xilio Therapeutics Q3 2026 net loss narrows 63% to $5.95 million
- Hidrovias do Brasil Q3 Recurring Adjusted EBITDA Falls 8% to R$ 303 Million
- XCharge Raises 2026 Revenue Outlook to $33.2 Million-$39.4 Million
- Arbutus Biopharma Swings to Q3 Net Income of $59.12 Million
- Nextech3D.ai Schedules Fiscal Q2 2027 Financial Results Webinar
- LCI Industries Rejects Monomoy's Revised Takeover Offer
- AXON ENTERPRISE, INC. : ARGUS RESEARCH CUTS TARGET PRICE TO $380 FROM $600
- Veradermics Q3 net loss widens to $21 million
- Pyxus Launches Offer to Exchange Debt for Shares and New Debt
- Zoetis Participates in Jefferies Global Healthcare Conference
- Helbor Controlling Shareholders Cut Direct Stake to Zero Following HBR Offer
- Sterling Metals Announces Fully Allocated Private Placement of Up to $12.5 Million
- MICROCHIP TECHNOLOGY <MCHP.O>: ARGUS RESEARCH CUTS TARGET PRICE TO $100 FROM $130
- FuelCell Energy Joins DOE Lab-Led AI Data Center Power Project
- HBR Realty Settles Share Exchange Offer for Helbor Control
- BRIEF-Kalaris Therapeutics Inc Q3 Operating Income USD -11.811 Million
- Abaxx Says Jeff Currie Appointed Non-Executive Chairman; Josh Crumb Continues as CEO
- HBR Realty Controlling Block Raises Stake to 56.121% From 52.462%
- Sprinklr Publishes Update to Financial Calendar
- Midland Exploration, Fresnillo Start Airborne Gravity Survey at La Peltrie Project
- Gibraltar Industries to Present at 18th Annual Southwest IDEAS Conference
- Pyxus launches debt-for-equity exchange offer for 2027 notes
- Ultrapar Buys Back 1,208,800 Shares for R$ 42.11 Million
- Arbutus Biopharma 3Q EPS 30c >ABUS
- Arbutus Biopharma 3Q Rev $299,000 >ABUS
- Energy Focus swings to Q3 2026 net income of $500,000 from year-earlier loss; Q3 2026 net sales rise to $4.8 million year over year
- Gain Therapeutics Q3 loss narrows as R&D costs fall
- POLLARD BANKNOTE LTD : RAYMOND JAMES CUTS TARGET PRICE TO C$22.5 FROM C$28
- Protalix presents PRX-115 Phase 2 gout trial update, expects top-line data in second half of 2027
- NEXUS INDUSTRIAL REIT <NXR_u.TO>: RAYMOND JAMES RAISES TARGET PRICE TO C$9 FROM C$8.25
- AI frenzy faces the public market test: Anthropic (ANT.US) IPO targets $64.4 billion in funding, with a valuation as high as $1.02 trillion
- ITAFOS INC <IFOS.V>: RAYMOND JAMES CUTS TARGET PRICE TO C$3 FROM C$3.75
- Electrica publishes update to financial calendar
- DIVERSIFIED ROYALTY CORP : RAYMOND JAMES CUTS TARGET PRICE TO C$4.4 FROM C$5
- Venture Global secures $3 billion revolving credit facility
- BARRICK MINING <B.N>: RAYMOND JAMES CUTS TARGET PRICE TO $55 FROM $56
- Hydro One subsidiary Hydro One Inc. reports Q3 net income of CAD 422 million, down from CAD 428 million
- ADENTRA INC : RAYMOND JAMES RAISES TARGET PRICE TO C$50 FROM C$47.5
- Helbor settles HBR Realty share-exchange offer for control
- VERISK ANALYTICS, INC. <VRSK.O>: RAYMOND JAMES RAISES TARGET PRICE TO $245 FROM $230
- Positivo Tecnologia majority shareholder decreases position by R$ 4.54 million
- Ovid Therapeutics presents OV329 epilepsy program, targets Phase 2 data in second half of 2027
- KODIAK GAS SERVICES INC <KGS.N>: RAYMOND JAMES CUTS TARGET PRICE TO $70 FROM $81
- FICO Says Delinquencies Rise Fastest Where Loan Originations Grow Most
- Quantinuum Joins Fourth Annual Cantor Convergence Conference
- TIDEWATER INC. <TDW.N>: ZEPHIRIN GROUP RAISES TO SELL FROM STRONG SELL; RAISES PRICE OBJECTIVE BY $7 TO $75
- Lensar 3Q Loss $4.72M >LNSR
- Scholar Rock Holding 3Q Loss $107.2M >SRRK
- Bitdeer Technologies Q3 Loss Widens, Revenue Rises
- --Earnings Flash (MANE) Veradermics Posts Q3 Net Loss $21M, vs. FactSet Est of $26.5M Loss
- Diamondback, KKR to Buy Deep Blue Stake From Five Point
- -- Earnings Flash (BOGO.V) Borealis Mining Company Reports Q4 Revenue $3.6M
- -- GUIDANCE: (AMBQ) Ambiq Micro, Inc. Expects Q4 Revenue Range $43.5M - $44.5M
- -- Earnings Flash (RIO.TO) Rio2 Limited Reports Q3 Revenue $115.4M
- -- Earnings Flash (RIO.TO) Rio2 Limited Posts Q3 Adjusted EPS $0.04
- -- Earnings Flash (AMBQ) Ambiq Micro, Inc. Reports Q3 Revenue $38.1M, vs. FactSet Est of $36.6M
- Hemlo Swings to Q3 Adjusted Net Income YoY
- -- GUIDANCE: (AMBQ) Ambiq Micro, Inc. Expects Q4 Adjusted EPS Range $-0.09 - $-0.03
- -- Earnings Flash (AMBQ) Ambiq Micro, Inc. Posts Q3 Adjusted Loss $0.05 per Share, vs. FactSet Est of $-0.16
- US Dollar Rises Early Tuesday Ahead of October Consumer Price Data
- D-Wave Quantum's Q3 Net Loss Narrows, Revenue Rises
- Hydro One Q3 Net Income Falls
- Scholar Rock's Q3 Net Loss Narrows, Registers Revenue; Shares Drop Pre-Bell
- Hemab Therapeutics Q3 Net Loss Narrows
- --Stifel Nicolaus Initiates Coverage on Mentari Therapeutics With Buy Rating, $30 Price Target
- Alliance Laundry Holdings' Q3 Adjusted Earnings, Net Revenues Increase; 2026 Revenue Growth Outlook Maintained
- Cantor Fitzgerald Initiates Academy Sports and Outdoors at Overweight With $89 Price Target
- --Jefferies Initiates City Therapeutics at Buy With $32 Price Target
- --Stifel Initiates City Therapeutics at Buy With $34 Price Target
- --Oppenheimer Initiates City Therapeutics at Outperform With $46 Price Target
- --Jefferies Initiates Coverage on Iambic Therapeutics With Buy Rating, $35 Price Target
- --JPMorgan Initiates Coverage on Sterling Infrastructure With Overweight Rating
- Commercial Metals CFO Paul Lawrence Plans to Retire; Kenji Hashimoto Named Deputy CFO
- Legend Biotech Swings to Q3 Adjusted Net Income, Revenue Increases
